Sveriges Riksbank
Share
RESULT OF RIKSBANK REVERSED AUCTIONS TREASURY BILLS
| Auction date | 2021-03-22 |
| Loan | JUN 2021 |
| Isin | SE0014555991 |
| Coupon, % | 0.00 |
| Maturity | 2021-06-16 |
| Tendered volume, SEK mln | 500 +/- 250 |
| Offered volume, SEK mln | 2,000 |
| Volume bought, SEK mln | 500 |
| Number of bids | 9 |
| Number of accepted bids | 5 |
| Average yield, % | -0.203 |
| Lowest accepted yield, % | -0.204 |
| Highest yield, % | -0.201 |
| Accepted at lowest yield, % | 33.33 |
| Auction date | 2021-03-22 |
| Loan | SEP 2021 |
| Isin | SE0014808747 |
| Coupon, % | 0.00 |
| Maturity | 2021-09-15 |
| Tendered volume, SEK mln | 500 +/- 250 |
| Offered volume, SEK mln | 2,500 |
| Volume bought, SEK mln | 500 |
| Number of bids | 14 |
| Number of accepted bids | 6 |
| Average yield, % | -0.201 |
| Lowest accepted yield, % | -0.203 |
| Highest yield, % | -0.201 |
| Accepted at lowest yield, % | 11.11 |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
DK
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
Aspo Plc12.12.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 12.12.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom